Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_assertion type Assertion NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_head.
- NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_assertion description "[SAR development of a series of 4-(indazol-3-yl)phenols has led to the identification of WAY-169916 an orally active nonsteroidal ligand with the potential use in the treatment of rheumatoid arthritis without the classical proliferative effects associated with estrogens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_provenance.
- NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_assertion evidence source_evidence_literature NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_provenance.
- NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_assertion SIO_000772 15588074 NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_provenance.
- NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_assertion wasDerivedFrom befree-20140225 NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_provenance.
- NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_assertion wasGeneratedBy ECO_0000203 NP874164.RABGUs39-P3Skx-q4FcKlXg5a5Ut2_BIYLLgmRhgPj6JM130_provenance.